Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bone marrow stromal function from patients after bone marrow transplantation

E O'Flaherty1, R Sparrow, J Szer

  • 1Clinical Haematology and Bone Marrow Transplantation, Alfred Hospital, Prahran, Victoria, Australia.

Bone Marrow Transplantation
|February 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Using expert-elicitation to deliver biodiversity monitoring priorities on a Mediterranean island.

PloS one·2022
Same author

Pre-Transplant Marital Status and Hematopoietic Cell Transplantation Outcomes

Current oncology (Toronto, Ont.)·2020
Same author

Worldwide Network for Blood and Marrow Transplantation (WBMT) recommendations for establishing a hematopoietic stem cell transplantation program in countries with limited resources (Part II): Clinical, technical and socio-economic considerations.

Hematology/oncology and stem cell therapy·2019
Same author

Human exposure to antibiotic resistant-Escherichia coli through irrigated lettuce.

Environment international·2018
Same author

The potential human exposure to antibiotic resistant-Escherichia coli through recreational water.

The Science of the total environment·2018
Same author

Are bougies gaining favour in videolaryngoscopy?

Anaesthesia·2018
Same journal

ALLOPLUS: allogeneic hematopoietic stem cell transplantation in children and adult people living with human immunodeficiency virus, a retrospective study of the SFGM-TC.

Bone marrow transplantation·2026
Same journal

Epigenetic priming with azacitidine-BEAM versus decitabine-BEAM conditioning for autologous transplantation in non-Hodgkin's lymphoma.

Bone marrow transplantation·2026
Same journal

CHIME: a novel HLA eplet model associates with non-relapse mortality in haploidentical hematopoietic cell transplant with post-transplant cyclophosphamide.

Bone marrow transplantation·2026
Same journal

Transplant outcomes for patients with severe acquired aplastic anemia over the age of 40 using busulfan, fludarabine, reduced-dose cyclophosphamide, and anti-thymocyte globulin conditioning regimen.

Bone marrow transplantation·2026
Same journal

A holistic prognostic model for leukemia-free survival after allogeneic transplantation in acute leukemia.

Bone marrow transplantation·2026
Same journal

Early software-assisted response predicts survival in a prospective cohort of 258 newly diagnosed cGvHD patients.

Bone marrow transplantation·2026
See all related articles

Bone marrow stromal cells in patients after bone marrow transplantation (BMT) show significantly reduced ability to support primitive hematopoietic stem cells, impacting recovery for years post-transplant. This compromise affects long-term hematopoietic support.

Area of Science:

  • Hematology
  • Stem Cell Biology
  • Immunology

Background:

  • Allogeneic bone marrow transplantation (BMT) is a critical therapy for hematologic malignancies.
  • Assessing the hematopoietic supporting capacity of bone marrow stroma post-BMT is crucial for understanding long-term recovery.
  • Long-term bone marrow culture (LTBMC) models are utilized to evaluate stromal cell function.

Purpose of the Study:

  • To evaluate the hematopoietic supporting ability of bone marrow stromal cells in patients following BMT.
  • To assess the functional capacity of bone marrow stroma to support primitive hematopoietic stem cells (CD34+/CD38-) post-transplant.

Main Methods:

  • A two-stage long-term bone marrow culture (LTBMC) system was employed.
  • Irradiated bone marrow stromal cells from BMT recipients were co-cultured with CD34+/CD38- cells from normal donors.

Related Experiment Videos

  • Granulocyte/macrophage colony-forming cell (GM-CFC) output was monitored weekly to assess hematopoietic support.

    • Main Results:

    • Neutrophil recovery was rapid post-BMT, but granulocyte/macrophage colony-forming cell (GM-CFC) recovery was significantly reduced in most patients up to 5 years.
    • 58% of patients exhibited compromised bone marrow stroma, with deficits in supporting primitive hematopoietic cells (CD34+/CD38-).
    • These deficits in hematopoietic support persisted for several years in some BMT recipients.

    Conclusions:

    • Bone marrow stroma in BMT recipients demonstrates compromised hematopoietic supporting ability, particularly for primitive stem cells.
    • The functional deficits in bone marrow stroma can persist for years, impacting long-term hematopoietic recovery.
    • LTBMC is a valuable tool for assessing stromal cell function and identifying long-term complications after BMT.